Cite
MLA Citation
I Parodis et al.. “PO.5.102 Pharmacokinetic modelling of belimumab in patients with lupus nephritis: intravenous and subcutaneous loading dose regimen justification.” Lupus science & medicine, vol. 9, n.d., pp. A80–A81. http://access.bl.uk/ark:/81055/vdc_100167559557.0x000011